SCHEMBL3269183

SCHEMBL3269183

OCc1cccn1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6628553 0.81
SCHEMBL21958211 0.78 HDAC6 (0.33)
SCHEMBL1244069 0.76 HDAC8 (0.53)
SCHEMBL7675118 0.76 NPC1 (0.39)
SCHEMBL11740436 0.71 ALDH1A1 (0.49)
SCHEMBL2058601 0.70
SCHEMBL11740193 0.68 TAAR1 (0.48)
SCHEMBL22006701 0.65 ADRA1A (0.35)
SCHEMBL21407447 0.65 NOTUM (0.42)
SCHEMBL543197 0.64 CA1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190247371-A1 METHODS FOR TREATING SMALL CELL LUNG CANCERS BY USING PHARMACEUTICAL COMPOSITIONS OR COMBINATIONS COMPRISING INDOLIZINO[6,7-B]INDOLE DERIVATIVES ACADEMIA SINICA (TW) 2019-08-15 US disclosed
EP-3515437-A1 METHODS FOR TREATING SMALL CELL LUNG CANCERS BY USING PHARMACEUTICAL COMPOSITIONS OR COMBINATIONS COMPRISING INDOLIZINO (6,7-B) INDOLE DERIVATIVES Academia Sinica (TW) 2019-07-31 EP disclosed
WO-2018057712-A1 METHODS FOR TREATING SMALL CELL LUNG CANCERS BY USING PHARMACEUTICAL COMPOSITIONS OR COMBINATIONS COMPRISING INDOLIZINO (6,7-B) INDOLE DERIVATIVES ACADEMIA SINICA (TW) 2018-03-29 WO disclosed
CN-103626995-A Preparation method for polyamides from glycol and diamine DU PONT 2014-03-12 CN disclosed
WO-2010049678-A2 TREATMENT OF ENERGY UTILIZATION DISEASES SUMMIT CORPORATION PLC (GB) 2010-05-06 WO disclosed
WO-2010029313-A1 ANTIINFECTIVE COMPOUNDS SUMMIT CORPORATION PLC. (GB) 2010-03-18 WO disclosed
US-4647576-A Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis WARNER-LAMBERT COMPANY (US) 1987-03-03 US disclosed
EP-0179559-A2 Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis WARNER-LAMBERT COMPANY (US) 1986-04-30 EP disclosed